Andrew Fein
Stock Analyst at HC Wainwright & Co.
(4.55)
# 242
Out of 5,127 analysts
568
Total ratings
52.57%
Success rate
24.13%
Average return
Main Sectors:
Stocks Rated by Andrew Fein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KALV KalVista Pharmaceuticals | Maintains: Buy | $27 → $37 | $14.78 | +150.34% | 17 | Jan 9, 2026 | |
| AMLX Amylyx Pharmaceuticals | Maintains: Buy | $16 → $20 | $14.22 | +40.65% | 21 | Nov 7, 2025 | |
| ALEC Alector | Maintains: Buy | $10 → $5 | $1.96 | +155.10% | 11 | Oct 22, 2025 | |
| UTHR United Therapeutics | Maintains: Buy | $400 → $500 | $473.12 | +5.68% | 17 | Sep 5, 2025 | |
| BIIB Biogen | Maintains: Buy | $187 → $194 | $193.81 | +0.10% | 22 | Aug 1, 2025 | |
| FULC Fulcrum Therapeutics | Upgrades: Buy | $4 → $12 | $10.23 | +17.30% | 18 | Jul 29, 2025 | |
| CADL Candel Therapeutics | Assumes: Buy | $23 | $5.77 | +298.61% | 1 | Jun 30, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $54 → $60 | $79.11 | -24.16% | 8 | Jun 26, 2025 | |
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $32 | $23.22 | +37.81% | 20 | Jun 26, 2025 | |
| VRTX Vertex Pharmaceuticals | Reiterates: Buy | $550 | $470.87 | +16.81% | 27 | Jun 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $149.54 | -19.75% | 15 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $4.67 | +71.31% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $6 → $2 | $5.23 | -61.76% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $35 | $42.40 | -17.45% | 14 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $14 | $8.86 | +58.01% | 18 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $35 | $31.97 | +9.49% | 14 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $14 | $5.63 | +148.67% | 16 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $78.93 | -4.98% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $68 | $72.89 | -6.71% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $38 | $16.99 | +123.66% | 12 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $25 | $17.53 | +42.61% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $32 | $20.84 | +53.55% | 22 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $6.30 | +376.19% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $16 | $22.22 | -27.99% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $24 | $13.29 | +80.59% | 19 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $3.11 | +285.85% | 16 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $77.82 | -51.17% | 6 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $168 | $139.56 | +20.38% | 20 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $11 | $2.48 | +343.55% | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.40 | +316.67% | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $13.67 | +60.94% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $120 → $20 | $13.98 | +43.06% | 16 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $1.47 | +716.33% | 12 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $5.45 | +138.53% | 14 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $8.28 | +32.85% | 10 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $6.48 | +254.94% | 14 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $0.98 | +1,426.41% | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $24.45 | +43.15% | 14 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $7.92 | +846.97% | 7 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $1.78 | +293.26% | 6 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.48 | +303.23% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.63 | +23,709.52% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $200 → $60 | $14.75 | +306.78% | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $5.56 | +169.78% | 1 | Apr 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $40 | $0.66 | +5,960.61% | 3 | Mar 16, 2022 |
KalVista Pharmaceuticals
Jan 9, 2026
Maintains: Buy
Price Target: $27 → $37
Current: $14.78
Upside: +150.34%
Amylyx Pharmaceuticals
Nov 7, 2025
Maintains: Buy
Price Target: $16 → $20
Current: $14.22
Upside: +40.65%
Alector
Oct 22, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $1.96
Upside: +155.10%
United Therapeutics
Sep 5, 2025
Maintains: Buy
Price Target: $400 → $500
Current: $473.12
Upside: +5.68%
Biogen
Aug 1, 2025
Maintains: Buy
Price Target: $187 → $194
Current: $193.81
Upside: +0.10%
Fulcrum Therapeutics
Jul 29, 2025
Upgrades: Buy
Price Target: $4 → $12
Current: $10.23
Upside: +17.30%
Candel Therapeutics
Jun 30, 2025
Assumes: Buy
Price Target: $23
Current: $5.77
Upside: +298.61%
Kymera Therapeutics
Jun 26, 2025
Maintains: Buy
Price Target: $54 → $60
Current: $79.11
Upside: -24.16%
ACADIA Pharmaceuticals
Jun 26, 2025
Reiterates: Buy
Price Target: $32
Current: $23.22
Upside: +37.81%
Vertex Pharmaceuticals
Jun 23, 2025
Reiterates: Buy
Price Target: $550
Current: $470.87
Upside: +16.81%
Jun 11, 2025
Maintains: Buy
Price Target: $90 → $120
Current: $149.54
Upside: -19.75%
May 29, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $4.67
Upside: +71.31%
May 29, 2025
Downgrades: Neutral
Price Target: $6 → $2
Current: $5.23
Upside: -61.76%
May 28, 2025
Maintains: Buy
Price Target: $29 → $35
Current: $42.40
Upside: -17.45%
May 27, 2025
Maintains: Buy
Price Target: $30 → $14
Current: $8.86
Upside: +58.01%
May 14, 2025
Maintains: Buy
Price Target: $47 → $35
Current: $31.97
Upside: +9.49%
May 14, 2025
Maintains: Buy
Price Target: $20 → $14
Current: $5.63
Upside: +148.67%
May 12, 2025
Maintains: Buy
Price Target: $80 → $75
Current: $78.93
Upside: -4.98%
May 12, 2025
Maintains: Buy
Price Target: $72 → $68
Current: $72.89
Upside: -6.71%
May 9, 2025
Maintains: Buy
Price Target: $46 → $38
Current: $16.99
Upside: +123.66%
May 8, 2025
Maintains: Buy
Price Target: $40 → $25
Current: $17.53
Upside: +42.61%
May 7, 2025
Maintains: Buy
Price Target: $80 → $32
Current: $20.84
Upside: +53.55%
May 6, 2025
Reiterates: Buy
Price Target: $30
Current: $6.30
Upside: +376.19%
May 5, 2025
Maintains: Buy
Price Target: $7 → $16
Current: $22.22
Upside: -27.99%
May 2, 2025
Maintains: Buy
Price Target: $81 → $24
Current: $13.29
Upside: +80.59%
May 1, 2025
Maintains: Buy
Price Target: $16 → $12
Current: $3.11
Upside: +285.85%
Apr 30, 2025
Reiterates: Buy
Price Target: $38
Current: $77.82
Upside: -51.17%
Apr 22, 2025
Maintains: Buy
Price Target: $185 → $168
Current: $139.56
Upside: +20.38%
Mar 28, 2025
Maintains: Buy
Price Target: $15 → $11
Current: $2.48
Upside: +343.55%
Mar 27, 2025
Reiterates: Buy
Price Target: $10
Current: $2.40
Upside: +316.67%
Mar 26, 2025
Reiterates: Buy
Price Target: $22
Current: $13.67
Upside: +60.94%
Mar 17, 2025
Downgrades: Neutral
Price Target: $120 → $20
Current: $13.98
Upside: +43.06%
Mar 14, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $1.47
Upside: +716.33%
Mar 7, 2025
Reiterates: Buy
Price Target: $13
Current: $5.45
Upside: +138.53%
Mar 6, 2025
Reiterates: Buy
Price Target: $11
Current: $8.28
Upside: +32.85%
Mar 6, 2025
Reiterates: Buy
Price Target: $23
Current: $6.48
Upside: +254.94%
Mar 6, 2025
Reiterates: Buy
Price Target: $15
Current: $0.98
Upside: +1,426.41%
Feb 28, 2025
Reiterates: Buy
Price Target: $35
Current: $24.45
Upside: +43.15%
Feb 18, 2025
Reiterates: Buy
Price Target: $75
Current: $7.92
Upside: +846.97%
Nov 2, 2023
Maintains: Buy
Price Target: $17 → $7
Current: $1.78
Upside: +293.26%
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $2.48
Upside: +303.23%
Jan 31, 2023
Reiterates: Buy
Price Target: $150
Current: $0.63
Upside: +23,709.52%
May 5, 2022
Downgrades: Neutral
Price Target: $200 → $60
Current: $14.75
Upside: +306.78%
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $5.56
Upside: +169.78%
Mar 16, 2022
Maintains: Neutral
Price Target: $80 → $40
Current: $0.66
Upside: +5,960.61%